Clinical Trial Update: Safety and Tolerability of GTX-104 Compared with Oral Nimodipine in Patients with ASAH [Phase 3]

View source ↗

Summary

Phase 3 clinical trial comparing GTX-104 with oral nimodipine to assess safety and tolerability in patients with aneurysmal subarachnoid hemorrhage; the study i…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Aneurysmal Subarachnoid Hemorrhage

Drugs mentioned

• GTX-104
• Nimodipine (Nimodipine)

Snippet

Sponsor: Grace Therapeutics Inc. | Conditions: Aneurysmal Subarachnoid Hemorrhage (aSAH) | Phase 3 | Status: ACTIVE_NOT_RECRUITING